Mythic Therapeutics: Funding, Investors & Team (Sep 2026)
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
Mythic Therapeutics has raised $103M across 1 funding round on record, the most recent a Series B of $103M announced in Dec 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mythic Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Mythic Therapeutics Funding Rounds
Mythic Therapeutics Founders and Leadership Team
Contact details for the Mythic Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Mythic Therapeutics Funding Compared to Other Biotechnology Startups
Mythic Therapeutics' latest round of $103M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mythic Therapeutics in Biotechnology and Waltham
Companies Similar to Mythic Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Mythic Therapeutics Funding FAQs
What does Mythic Therapeutics do?
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets.
How much funding has Mythic Therapeutics raised?
Mythic Therapeutics has raised $103M across 1 round on record. The most recent is a Series B of $103M announced in Dec 2021.
When did Mythic Therapeutics last raise funding?
Mythic Therapeutics' most recent funding round on record is a Series B of $103M, announced in Dec 2021.
Who is the CEO of Mythic Therapeutics?
Alex Nichols is listed as CEO at Mythic Therapeutics.
Where is Mythic Therapeutics headquartered?
Mythic Therapeutics is based in Waltham, Massachusetts, United States.
How many employees does Mythic Therapeutics have?
Mythic Therapeutics is in the 11-50 employee band.
How does Mythic Therapeutics' funding compare to other Biotechnology startups?
Mythic Therapeutics' latest round of $103M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Mythic Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mythic Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.